Parametrica Management LTD Bluebird Bio, Inc. Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$2.94 - $5.23 $264,908 - $471,249	90,105 New	90,105 $374,000
Q1 2022 May 10, 2022	SELL	$4.07 - $10.6 $163,390 - $425,537	-40,145 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$8.96 - $16.31 $28,904 - $52,616	3,226 Added 8.74%	40,145 $401,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $72,981 - $136,353	-6,493 Reduced 14.96%	36,919 $706,000
Q2 2021 Aug 13, 2021	BUY	$18.04 - $22.09 $102,828 - $125,913	5,700 Added 15.11%	43,412 $1.39 Million
Q1 2021 May 14, 2021	BUY	$16.59 - $33.89 $625,642 - $1.28 Million	37,712 New	37,712 $1.08 Million

112

61.5M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $485M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.